ABTvsCI
Abbott LaboratoriesvsCigna Group. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Abbott Laboratories
$91.7
-26.39%
Cigna Group
$279.72
+1.31%
60-day price, rebased to 100
Round-by-round
Valuation upside
-14.50% vs +961.30% to DCF fair value
Balance-sheet strength
Altman Z 4.61 vs 2.53
Fundamental quality
Piotroski 6.00 vs 7.00 (of 9)
Growth + margins
Rule-of-40 22.40 vs 15.50
60-day momentum
-15.89% vs +2.05% price return
Market-cap liquidity
$161.5B vs $71.2B
Verdict
Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onABTorCI
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.